Effect of Individualized Homoeopathic Medicine selected using Boerickes Pocket Manual Repertory in cases of Menopausal Syndrome assessed by Menopausal Rating Scale: A Prospective Interventional Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Marked Improvement
研究概览
简要总结
This study addresses menopausal syndrome, a common condition characterized by vasomotor, psychological, somatic, and urogenital symptoms resulting from oestrogen deficiency in middle-aged women, which has a high epidemiological burden due to increasing life expectancy. There is a research gap in systematically generated clinical evidence evaluating the effectiveness of individualized homoeopathic treatment using standardized assessment tools. The study uses the Menopause Rating Scale (MRS) to assess symptom severity and therapeutic response. This prospective interventional single arm clinical study aims to evaluate the effect of individualized homoeopathic medicines selected through Boericke’s Pocket Manual Repertory in cases of Menopausal Syndrome with objectives to assess baseline symptoms, monitor improvement. Forty eligible participants will be recruited from Jawaharlal Nehru Homoeopathic Medical College and Hospital, Vadodara, Gujarat, over a study period of one year. This prospective study expects to demonstrate a significant reduction in MRS scores, supporting the role of individualized homoeopathy as a safe and effective management option for menopausal syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- Female
入选标准
- •Women Aged 40-60 Years with Natural Menopause Stage 1 to Stage 2B According to Menopausal Staging by Dr Behram Anklesaria
- •Women presenting with Menopausal Symptoms with a Menopausal Rating Scale Score less than or is Equal to
- •All Socio- Economic Status.
- •Patients who willing to give Informed Consent and Maintaining Follow Up.
排除标准
- •Surgical or Chemically induced Menopause.
- •Women who are currently on or have taken Hormonal Replacement Therapy or other Alternative Therapies.
- •Known or Suspected Malignancy.
- •Presence of Major or Sever Systemic Illness.
结局指标
主要结局
Marked Improvement
时间窗: 6 Months
Moderate Improvement
时间窗: 6 Months
Mild Improvement
时间窗: 6 Months
No Significant Improvement
时间窗: 6 Months
Status Quo
时间窗: 6 Months
Any Increase in Menopausal Rating Scale Score will be counted as worse
时间窗: 6 Months
次要结局
未报告次要终点
研究者
Dr Asmabanu Patel
Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University
